Revenue - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytosorbents Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Revenue
$37.2m
CAGR 3-Years
-6%
CAGR 5-Years
10%
CAGR 10-Years
25%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.8B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.2B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$21.4B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.7B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.6B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
14%

Cytosorbents Corp
Revenue Breakdown

Breakdown by Geography
Cytosorbents Corp

Total Revenue: 36.3m USD
100%
All Other Countries: 18.1m USD
49.7%
Germany: 13m USD
35.7%
United States: 5.3m USD
14.5%

Breakdown by Segments
Cytosorbents Corp

Not Available

See Also

What is Cytosorbents Corp's Revenue?
Revenue
37.2m USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Revenue amounts to 37.2m USD.

What is Cytosorbents Corp's Revenue growth rate?
Revenue CAGR 10Y
25%

Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Cytosorbents Corp have been -6% over the past three years , 10% over the past five years , and 25% over the past ten years .

Back to Top